Language: English
Physician profile
Dr. med. Svenja Straßburg
Physician · Department of Pulmonary Medicine
Research consultant, Department of Pulmonary Medicine · Ruhrlandklinik Essen
This profile summarises the career and qualifications of Dr. med. Svenja Straßburg factually and with sources. The choice of physician and clinic always rests with the patient.
Profile summary and areas of expertise
Svenja Straßburg is a research consultant in the Department of Pulmonary Medicine at Ruhrlandklinik in Essen and a member of the medical team of the Cystic Fibrosis Centre for Adults. In 2022, Svenja Straßburg obtained her doctorate at the University of Duisburg-Essen with a thesis on respiratory rate as a monitoring marker in cystic fibrosis. The publications of Svenja Straßburg focus mainly on cystic fibrosis in adulthood, on contactless measurement of breathing and sleep and on CFTR modulator therapy.
- Cystic fibrosis (mucoviscidosis) in adulthood
- Clinical research
- Contactless monitoring of breathing and sleep
Clinical work and institutions
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen (MedVici profile of the institution)
Klinik für Pneumologie
- currentResearch consultant, medical team of the Cystic Fibrosis Centre for Adults
Qualifications and training
- 2022Doctorate (Dr. med.), University of Duisburg-Essen (cumulative dissertation)
Publications, talks and media
Documented contributions directly related to Dr. med. Svenja Straßburg, grouped by type and listed newest first within each type. Every title links to the original source.
Specialist publications according to the author affiliation – no statement about treatment success or the quality of the institution. MedVici Health currently does not show cancer-related publications.
Doctoral thesis (1)
- Respiratory rate as a marker for treatment management in patients with cystic fibrosis (original source, opens in a new window)
Dissertation (kumulativ), Universität Duisburg-Essen (Deutsche Nationalbibliothek)
Scientific publications (11)
- Interferon-γ-response to mycobacterial glycopeptidolipids in patients with pulmonary non-tuberculous mycobacterial infection (original source, opens in a new window)
Medical Microbiology and Immunology (PubMed 42776260)
- KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype (original source, opens in a new window)
Journal of Clinical Medicine (PubMed 42355723)
- How personality influences health outcomes and quality of life in adult patients with cystic fibrosis (original source, opens in a new window)
BMC Pulmonary Medicine (PubMed 37264349)
- Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis (original source, opens in a new window)
Frontiers in Pharmacology (PubMed 37229253)
- Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system (original source, opens in a new window)
BMC Pulmonary Medicine (PubMed 35148739)
Contact via MedVici
Questions about this profile and about MedVici Health's services for patients are answered by MedVici Health. Please do not send medical reports or other health data by email — there is an encrypted channel for documents.
Disclosure: Ruhrlandklinik is listed on MedVici Health with a clinic profile. Its managing director, Jürgen Schlebrowski, is a member of the MedVici Health Board of Advisors.
Reference profile based on publicly available information. No business relationship with MedVici Health is implied or claimed.
MedVici Health does not refer patients to specific physicians; patients choose their physician and clinic themselves.
Professional details based on publicly available information from the institution and bibliographic records, as of 19.10.2026.